Wed, 30th Dec 2020 07:30
LONDON, Dec 30 (Reuters) - The approval of a COVID-19
vaccine developed by the University of Oxford and AstraZeneca on
Wednesday was a "triumph for British science", Prime Minister
Boris Johnson said.
"It is truly fantastic news - and a triumph for British
science - that the @UniofOxford/@AstraZeneca vaccine has been
approved for use," Johnson tweeted.
(Reporting by Guy Faulconbridge and Paul Sandle, editing by
David Milliken)
(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...
(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Ba...
AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III t...
(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or ...
(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.
Astrazeneca (AZN)